capecitabine has been researched along with Hemorrhage, Peptic Ulcer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruzzese, JL; Amos, C; Charnsangavej, C; Crane, CH; Delclos, ME; Ellis, LM; Evans, DB; Ho, L; Lee, JE; Ng, C; O'Reilly, M; Pisters, PW; Tamm, EP; Wolff, RA; Xiong, HQ | 1 |
1 trial(s) available for capecitabine and Hemorrhage, Peptic Ulcer
| Article | Year |
|---|---|
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Digestive System; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreaticoduodenectomy; Peptic Ulcer Hemorrhage; Radiotherapy, Adjuvant; Treatment Outcome | 2006 |